Calling the implementation of the Affordable Care Act (better known as
"Obamacare") controversial would be a gross understatement, but the
actual effects on the med-tech space are arguably less controversial at
this point. Healthcare utilization has not picked up significantly and
multiple companies have reported minimal recoveries in procedure/product
volumes. What's more, while there has been a wave of M&A in the
sector, it has been more about leveraging costs and establishing strong
positions as hospitals become increasingly aggressive.
Read more here:
The Truth Behind Obamacare's Job-Killing Tax
No comments:
Post a Comment